Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir-William-Osler, Room 1303, Montréal, Québec H3G 1Y6, Canada.
Pharmacol Rev. 2013 Feb 13;65(2):545-77. doi: 10.1124/pr.111.005603. Print 2013 Apr.
Gβγ subunits from heterotrimeric G proteins perform a vast array of functions in cells with respect to signaling, often independently as well as in concert with Gα subunits. However, the eponymous term "Gβγ" does not do justice to the fact that 5 Gβ and 12 Gγ isoforms have evolved in mammals to serve much broader roles beyond their canonical roles in cellular signaling. We explore the phylogenetic diversity of Gβγ subunits with a view toward understanding these expanded roles in different cellular organelles. We suggest that the particular content of distinct Gβγ subunits regulates cellular activity, and that the granularity of individual Gβ and Gγ action is only beginning to be understood. Given the therapeutic potential of targeting Gβγ action, this larger view serves as a prelude to more specific development of drugs aimed at individual isoforms.
三聚体 G 蛋白的 Gβγ亚基在细胞信号转导方面发挥着广泛的作用,它们通常可以独立地或与 Gα亚基协同发挥作用。然而,“Gβγ”这个名称并没有充分体现出这样一个事实,即哺乳动物已经进化出 5 种 Gβ和 12 种 Gγ同工型,它们的作用远远超出了细胞信号转导的经典作用。我们探讨了 Gβγ亚基的系统发育多样性,以期了解它们在不同细胞细胞器中的扩展作用。我们认为,不同 Gβγ亚基的特定含量调节细胞活性,而单个 Gβ和 Gγ作用的粒度才刚刚开始被理解。鉴于靶向 Gβγ作用的治疗潜力,这种更广泛的观点是为更具体地开发针对个别同工型的药物做准备。